SKI Market

Indian Indices

Sensex

85,323.75 135.15
( 0.16%)

Global Indices

Nasdaq

48,084.29 -303.78
(-0.63%)

Dow Jones

6,866.50 -50.74
(-0.73%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.87 0.03
(0.03%)

EUR-INR

105.50 -0.18
(-0.17%)

GBP-INR

120.91 -0.28
(-0.23%)

JPY-INR

0.57 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

62.73

3409.61

EPS(TTM)

Face Value()

Div & Yield %

5.42

0.03

Back

Graviss Hospitality reports consolidated net loss of Rs 1.30 crore in the September 2025 quarter

Nov 14,2025

Net loss of Graviss Hospitality reported to Rs 1.30 crore in the quarter ended September 2025 as against net profit of Rs 8.91 crore during the previous quarter ended September 2024. Sales declined 2.70% to Rs 12.26 crore in the quarter ended September 2025 as against Rs 12.60 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	12.26	12.60	-3
OPM %	-2.85	7.22	-
PBDT	-0.38	1.89	PL
PBT	-2.11	0.42	PL
NP	-1.30	8.91	PL

85,323.75 135.15 ( 0.16%)

48,084.29 -303.78 (-0.63%)

6,866.50 -50.74 (-0.73%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.87 0.03 (0.03%)

105.50 -0.18 (-0.17%)

120.91 -0.28 (-0.23%)

0.57 0.00 (-0.26%)